Petr Triska

Petr Triska

Auto-generated profile, based on publicly available information

Petr Triska

Archaeogenetics Laboratory Institute of Archaeology of the Academy of Sciences of the Czech Republic Prague Czech Republic

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2021 in American Journal of Biological Anthropology
Verified
Journal Article
Closed access
PDF file
IKIva Kulichová
Iva Kulichová
MMMédéric Mouterde
Médéric Mouterde
MMMohammed G. Mokhtar
Mohammed G. Mokhtar
IDIssa Diallo
Issa Diallo
PTPetr Tříska
Petr Tříska
VČViktor Černý
Viktor Černý

1 October 2025 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
ITIlona Tietzova
Ilona Tietzova
DSDana Sochorova
Dana Sochorova
PTPetr Triska
Petr Triska
RRRebecca C. Rancourt
Rebecca C. Rancourt
MOMarek Omelka
Marek Omelka
MTMarkéta Tesařová
Markéta Tesařová
Nuclear mitochondrial DNA sequences (NUMTs) represent mitochondrial DNA fragments integrated into the nuclear genome with potential clinical significance particularly in the pathology of cancer which have be identified in recent whole-genome sequencing (WGS) studies. Combining NUMT in silico analysis on WGS from The Cancer Genome Atlas with further characterize with molecular-genomic experiments (PCR assay and sequencing) across lung adenocarcinoma (LUAD) patient cohort tumor samples and incorporating important clinical parameters. Our molecular analysis of 298 LUAD samples revealed a RSPO1 gene NUMT insertion in approximately 31% of cases (29% heterozygous, 2% homozygous). This RSPO1-NUMT insertion’s presence was observed across matched blood, healthy lung, and tumor samples confirming its germline origin. Notably, homozygous carriers exhibited significantly earlier disease onset (mean age: 54 vs. 63.3 years; P=0.04) and a trend toward advanced-stage disease at diagnosis compared to no NUMT-insertion or heterozygous individuals. We report a novel NUMT insertion of the RSPO1 gene, which is a key regulator in the oncogenic WNT signaling pathway. Our findings also highlight technical challenges in NUMT detection across genome builds and databases, with significant discrepancies observed between reference genomes and population frequency estimates. We propose that this homozygous RSPO1-NUMT insertion may represent a previously unrecognized predisposing factor for LUAD development and progression through modulation of RSPO1 expression and subsequent WNT pathway activation, potentially influencing tumor vascularization, drug response, and disease progression.